Presentations -
-
A Murine Model Presenting Leukemic Transformation from MPN with a Mutation in Epigenetic Modifier.
66th ASH Annual Meeting
-
Characteristics and Consequences of Platelets Derived from JAK2-Mutated Megakaryocytes
66th ASH Annual Meeting
-
Clinical significance of anti-M in pregnancy: A BEST Collaborative study
2024 Annual Meeting of AABB 2024.10
-
Suggestive findings for transfusion care from the prospective survey of hematopoietic cell infusion-related adverse events.
Annual Meeting of the Taiwan Society of Blood Transfusion, 2023. 2023.12
-
Prospective survey of hematopoietic cell infusion-related adverse events in Japan
BEST-JSTMCT Transfusion Medicine Updates Education Program 2023.3
-
Current treatment strategies and choice of JAK inhibitors for myelofibrosis
THE 15th JSH International Symposium 2025.5
-
合併症への対策を考慮したPV治療
ジャカビ錠１０周年Web Seminar 2025.4
-
造血細胞産物の解凍作業の実態調査について（第二報）
第126回 日本輸血・細胞治療学会 東北支部例会 2025.3
-
HLA-KMR analysis of HLA loss in relapsed childhood leukemia after HLA-haploidentical transplantation
2025.2
-
Study on the safety of hematopoietic stem cell donation from young donors due to a lowered adult age
2025.2
-
Current treatment strategies and choice of JAK inhibitors for myelofibrosis
2025 Highlights of ASH in Asia-Pacific Breakfast Symposium 2025.2
-
1st lineにおけるオムジャラのポジショニング
GSK Myelofibrosis Forum 2024 2024.12
-
骨髄線維症治療のUpdate
GSK Myelofibrosis Webinar in Tohoku 2024.11
-
ＪＡＫ２変異による巨核球分化経路の変化が血小板機能の異常を引き起こす
第29回造血器腫瘍研究会 2024.11
-
ＰＶ血栓・進行リスクの予測と対策
Novartis Hematology Web Seminar 2024.11
-
MPNにおけるロペグインターフェロン α-2bの作用メカニズム
福島県 ベスレミ発売1周年記念講演会 2024.10
-
Ropeg IFN-αの作用メカニズム
東日本ベスレミ発売1周年記念講演会（WEB開催） 2024.10
-
Skewed differentiation of megakaryocytes in JAK2-V617F hematopoiesis alters platelet function
2024.10
-
小児白血病の HLA 半合致移植後再発における HLA-KMR 法を用いた HLA loss の解析
第32回日本組織適合性学会大会 2024.9
-
今、骨髄線維症の治療に求められること
GSK Myelofibrosis Webinar Sep 2024.9